Table 1.
Authors |
Sample size |
Treatment duration |
|
Symptom recurrence rates |
Comparator recurrence rate |
|||
---|---|---|---|---|---|---|---|---|
9 months | 12 months | 18 months | 24 months | 36 months | ||||
Kane J et al.
[24]. |
28 |
Not specified |
|
41% |
|
|
|
0% |
Crow T et al.
[26]. |
120 |
Not specified |
|
|
|
62% |
|
46% |
Gitlin M et al.
[21]. |
53 |
3 months in remission |
|
78% |
|
96% |
|
- |
Wunderink L et al.
[25]. |
161 |
6 months in remission |
|
|
43% |
|
|
21% |
Chen E. et al.
[22]. |
178 |
12 months + |
|
79% |
|
|
|
41% |
Gaebel W. et al.
[27]. |
44 |
12 months |
|
57% |
|
|
|
4% |
Boonstra G. et al.
[23]. |
20 |
12 months min remission |
82% |
|
|
|
|
12% |
Emsley R et al. [10]. | 33 | 24 months | 79% | 94% | 97% | - |